Evidence map›Paper›PMID 42897621›Full record

ReviewBMC global and public health2026

Public brain health: a framework for action to promote and safeguard brain health.

Timothy Daly, Dorothee Horstkötter, Harris Anthony Eyre, Emily Murphy, Seth Alan Gale, Lisa Cosgrove, Davide Bruno, Eoin Cotter, Andrea Slachevsky, James Rupert Fletcher and 16 more

Abstract readReview
In one paragraph

Review in BMC global and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Timothy DalyBordeaux Population Health, University of Bordeaux & INSERM, UMR 1219, Bordeaux, France.
Dorothee HorstkötterDepartment of Health, Ethics and Society, Mental Health and Neuroscience Research Institute (MHeNs), Maastricht University, Maastricht, the Netherlands.
Harris Anthony EyreGlobal Brain Economy Initiative, Rice University, Houston, TX, USA.
Emily MurphyUniversity of California, College of the Law, San Francisco, USA.
Seth Alan GaleMass General Brigham Memory Disorders Division, Department of Neurology, Harvard Medical School, Boston, USA.
Lisa CosgroveApplied Ethics Center, University of Massachusetts-Boston, Boston, USA.
Davide BrunoSchool of Psychology, Liverpool John Moores University, Liverpool, UK.
Eoin CotterGlobal Brain Health Institute (GBHI), Trinity College Dublin, Dublin, Ireland.
Andrea SlachevskyGerosciences Center for Brain Health and Metabolism (GERO), Santiago, Chile.
James Rupert FletcherSchool of Management, University of Bath, Bath, UK.
Lindsay WallaceDepartment of Community Health & Epidemiology, Dalhousie University, Halifax, Canada.
Abel Wajnerman-PazInstituto de Éticas Aplicadas, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
Jennifer Jaie ManlyTaub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, USA.
Jonathan FullerDepartment of History and Philosophy of Science, University of Pittsburgh, Pittsburgh, USA.
Stella-Maria PaddickTranslational and Clinical Research Institute, Newcastle University, Newcastle, UK.
Romain ManetDepartment of Cranial Neurosurgery, Neurological Hospital Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
C Elizabeth ShaabanDepartment of Health Promotion and Development, School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA.
Marcello IencaInstitute for History and Ethics in Medicine, TUM School of Medicine and Health, School of Social Sciences & Technology, Munich, Germany.
Andrea Sylvia WinklerDepartment of Neurology, Center for Global Health, TUM University Hospital, Technical University of Munich, Munich, Germany.
Eider Arenaza-UrquijoBarcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Carol BrayneCambridge Public Health, University of Cambridge, Cambridge, CB2 0SR, UK.
Agustín IbáñezGlobal Brain Health Institute (GBHI), Trinity College Dublin, Dublin, Ireland.
Steffi Riedel-HellerInstitute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Leipzig, Germany.
Edo RichardDept of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, the Netherlands.
Sebastian Walsh *Cambridge Public Health, University of Cambridge, Cambridge, CB2 0SR, UK.
Carole Dufouil *Bordeaux Population Health, University of Bordeaux & INSERM, UMR 1219, Bordeaux, France. carole.dufouil@u-bordeaux.fr.

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
TREATMENT OF DEPRESSION IN ALZHEIMER'S DISEASEP50AG005133 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECKER, JAMES T. · 1985 to 2019
$43.0M
Research Education ComponentP30AG066468 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOWARD J AIZENSTEIN · 2020 to 2026
$29.4M
An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populationsR01AG075775 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARIA LUISA GORNO TEMPINI, Adolfo Martin Garcia · 2023 to 2026
$7.2M
US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative ResearchR01AG057234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Claudia Duran-Aniotz, Agustin M. Ibanez · 2019 to 2026
$6.1M
Circadian Disturbance and Dementia in Latin AmericaR01AG083799 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Kun Hu, Agustin M. Ibanez · 2023 to 2026
$3.0M
Novel Story Recall Measures as Indicators of Cognitive Decline Associated with Alzheimer's Disease and Related Disorders Biomarkers: A Collaborative Study of Existing DataR01AG070940 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Kimberly D Mueller · 2021 to 2026
$2.8M
Brain CHEC-AC (Brain and Cognitive Health Equity Campaign for Allegheny County)U01NS141777 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JENNIFER Hagerty LINGLER, C. Elizabeth Shaaban · 2024 to 2026
$2.2M
Population neuroscience of sex differences in the Alzheimer's disease biomarker cascade: The role of cerebral small vessel diseaseK01AG071849 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI C. Elizabeth Shaaban · 2022 to 2026
$629k
Ministère de l'Enseignement supérieur et de la Recherche MEMENTONIA NIH HHS K01 AG071849NIA NIH HHS P01 AG019724NIA NIH HHS P30 AG066468NIA NIH HHS P50 AG005133NIA NIH HHS R01 AG057234NIA NIH HHS R01 AG070940NIA NIH HHS R01 AG075775NIA NIH HHS R01 AG083799NIDA NIH HHS 75N95022C00031NINDS NIH HHS U01 NS141777Wellcome Trust
6 · The paper itself

Abstract

The promotion of brain health has generally been undertaken at the level of individuals, for instance, in the quest for precision treatments for persons with, or at high risk of, neurological disorders. But the growing global burden of neurological conditions and the increasing understanding of the brain's central role in all facets of human life have spurred interest in public health approaches to the brain that emphasise population-level strategies benefitting everyone as part of a "brain health for all" vision of society. This article defines the emerging concept of public brain health as intersectoral action to establish brain health priorities, empower communities, and reduce health inequities, with the ultimate goal of improving brain health at the population level across the lifetime. We propose a framework to promote and safeguard population brain health with the following key elements: co-defining priorities with communities, balancing prevention strategies, and reducing global gaps in brain health through ambitious policy-making. Public brain health calls for collective responsibility to maximise brain health equity across the life course.

Indexed as

Brain healthBrain health equityBrain health for allCollective responsibilityIntersectoral actionNeurological conditionsPolicyPreventionPublic healthResearch

Identifiers

PMID42897621
PMCPMC13682159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.